This pioneer function is of particular importance in gene expression of endocrine-related cancers, including breast and prostate cancers as FoxA1 is a key cooperating factor for the nuclear hormone receptors, estrogen receptor-α (ER), and androgen receptor (AR) (1, 2). This evidence concerns the gene AR and prostate carcinoma.